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Abstract. The development of good quality and affordable ultrasound machines has led to the establishment and
implementation of numerous point-of-care ultrasound (POCUS) protocols in various medical disciplines. POCUS for
major infectious diseases endemic in tropical regions has received less attention, despite its likely even more pro-
nounced benefit for populations with limited access to imaging infrastructure. Focused assessment with sonography for
HIV-associated TB (FASH) and echinococcosis (FASE) are the only two POCUS protocols for tropical infectious dis-
eases, which have been formally investigated and which have been implemented in routine patient care today. This
review collates the available evidence for FASH and FASE, and discusses sonographic experiences reported for urinary
and intestinal schistosomiasis, lymphatic filariasis, viral hemorrhagic fevers, amebic liver abscess, and visceral leishman-
iasis. Potential POCUS protocols are suggested and technical as well as training aspects in the context of resource-
limited settings are reviewed. Using the focused approach for tropical infectious diseases will make ultrasound diagnosis
available to patients who would otherwise have very limited or no access to medical imaging.
INTRODUCTION
Ultrasound (US) has been used to aid diagnosis and to
guide therapy in a large number of tropical infectious diseases
for a long time.1 During the past two decades, technological
advances have improved image quality and significantly
reduced the size and price of US equipment. As a result, US
has been established as a point-of-care test in clinical deci-
sion making and for procedural guidance in various medical
specialties.2 Point-of-care ultrasound (POCUS) is one of the
few novel diagnostic tools to which the criticism of inflation-
ary use of the term point-of-care does not apply.3 Emergency
medicine (EM) physicians have pioneered and greatly
advanced the point-of-care application of US. Today, the
“focused assessment with sonography for trauma” (FAST)
protocol is not only well recognized as a standardized diag-
nostic test in emergency departments, but also constitutes an
integral part of diagnostic algorithms and EM training.4–7
The fundamental difference between POCUS and conven-
tional US examination is that POCUS is performed by the
treating physician who aims to answer simple, usually binary
questions relevant to immediate patient management (e.g., “Is
there a pleural effusion, yes or no?”). POCUS is not a com-
prehensive US assessment.8 Diagnoses for which POCUS is
suitable should fulfill two criteria: 1) diagnosis must be rele-
vant to consecutive treatment decision making and 2) diagno-
sis must be easily and accurately recognizable by physicians
applying US without the necessity for extended US training.
Whereas patients’ benefit from POCUS in affluent settings is
mainly a reduced time to diagnosis and further management,
POCUS in resource-constrained settings provides the addi-
tional benefit that it is frequently the only diagnostic imaging
modality available.9,10
This review first describes the development and applica-
tion of “focused assessment with sonography for human
immunodeficiency virus (HIV)–associated tuberculosis (TB)”
(FASH),11–16 which is the most widely studied and implemented
application of POCUS in infectious diseases to date. Sub-
sequently, other infectious diseases, endemic in tropical or
resource-limited settings and accounting for significant mor-
bidity and mortality in affected populations and for which
POCUS has been investigated or for which POCUS may be
a potential diagnostic tool, are reviewed and discussed. In
view of the required focused approach of POCUS, it is impor-
tant not only to define diagnostic criteria and test accuracy for
each disease, but also to identify the target population in which
the diseases of interest are highly prevalent and for whom
POCUS will therefore be valid and most beneficial (e.g., HIV/
TB coinfection in South Africa, echinococcosis in rural Argentina,
or the Kenyan Turkana region). Finally, technical and teach-
ing considerations are discussed.
FOCUSED ASSESSMENT WITH SONOGRAPHY
FOR HIV/TB
TB is one of the most frequent opportunistic infections
in HIV patients living in tropical countries and constitutes
an immense problem in sub-Saharan Africa and beyond.17
Extrapulmonary TB (EPTB) is seen more frequently in immu-
nocompromised patients and is more difficult to diagnose than
pulmonary TB. Disseminated TB is a major cause of death in
patients with HIV.18 Clinical symptoms are fever, weight loss,
and night sweats, possibly with cough, shortness of breath, or
other focal symptoms; frequently, cardinal signs and symptoms
are less clearly evident in HIV coinfected individuals.
*Address correspondence to Sabine Bélard, Department of Pediatric
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The diagnosis of EPTB in HIV-infected patients is challeng-
ing but vital to patient management. The majority of EPTB
patients in resource-poor settings are diagnosed on the basis
of clinical case definitions (e.g., World Health Organization
[WHO]19) and only in a minority of cases is microbiological
confirmation feasible. The value of US for diagnosing EPTB
has long been recognized. The sonographic features sugges-
tive of EPTB, in populations with a high prevalence of HIV/
TB coinfection, are as follows:
1. Pleural effusion, particularly when unilateral. In a study
from sub-Saharan Africa, unilateral pleural effusion was
caused by TB in over 90% of cases and was highly associ-
ated with HIV infection.20
2. Pericardial effusion is consistently reported to be due to
TB and to be associated with HIV coinfection in the major-
ity of cases in Africa.21 Pericardial fluid can easily be iden-
tified by POCUS,22 as well as its hemodynamic significance
and potential need for pericardiocentesis.23
3. Although not included in current WHO guidelines, enlarged
abdominal lymph nodes and splenic microabscesses have
been repeatedly reported as characteristic findings of
abdominal TB in HIV-infected patients (Figure 1A).24
Lymph nodes affected by TB present as hypoechoic round
structures and are considered pathological when larger
than 1.5–2 cm. Abdominal tuberculous lymphadenopathy
is frequently located in the upper abdomen, for example,
in the liver hilum, around the celiac axis and in the para-
aortic area. In some cases, lymphadenopathy can also be
found in the mesentery of the caecum (especially in cases
of cecal involvement of TB) and in the splenic hilum.
Splenic microabscesses are visible as multiple hypoechoic
lesions between 0.5 and 1 cm, in an often enlarged spleen
(Figure 1B). Presence of ascites can also be a sign of perito-
neal TB, especially, if further features suggestive of abdomi-
nal TB are demonstrated.
The feasibility and success of training clinicians to accu-
rately detect abdominal lymphadenopathy and splenic micro-
abscesses through short courses, using a curriculum developed
in South Africa, has been demonstrated.25 It has also been
documented extensively in EM that pleural,26 pericardial,27
and ascitic4 fluid can be detected by POCUS with high sensi-
tivity and specificity. There is no reason to doubt the similar
value of POCUS for the detection of effusions and ascites
secondary to infectious diseases. As a logical consequence, a
single POCUS protocol for EPTB (FASH) has been compiled
using the US views of FAST and US views for detection
of abdominal lymphadenopathy and splenic microabscesses11
(Figure 2). Because of the high prevalence of HIV/TB coin-
fection, FASH has become one of the most frequently used
POCUS modules in South Africa.15 Further studies showed
that in approximately 25% of patients with a FASH examina-
tion suggesting EPTB, the patient’s chest X-ray was not sug-
gestive of TB, indicating a significant proportion of patients
in whom the diagnosis will be missed if only chest X-ray is
performed as part of their diagnostic TB work-up.13 The use of
FASH in pediatric patients is currently under investigation, but
preliminary data indicate that FASH is also applicable in the
pediatric population.16 An evaluation of FASH as a tool to
monitor response to treatment in HIV-infected patients with
EPTB showed that the persistence of positive findings, after
a treatment period of 3 months, is an indicator of treatment
complications such as mycobacterial resistance, poor compli-
ance, or immune reconstitution inflammatory syndrome.14 It
needs to be emphasized that a definitive diagnosis of the etiol-
ogy underlying FASH findings is not possible by US only;
however, in a high-prevalence setting, commencing TB treat-
ment based on clinical and sonographic findings and observing
the patient’s clinical and sonographic response is justified.28
FIGURE 1. (A) Epigastric transverse view: enlarged round hypoechoic tuberculous lymph nodes behind the liver in the area of the celiac
trunk. (B) Left longitudinal flank view: enlarged spleen with small hypoechoic lesions (arrow) due to tuberculous microabscesses.
FIGURE 2. Ultrasound (US) probe positions used in focused assess-
ment with sonography for human immunodeficiency virus–associated
tuberculosis (FASH) protocol. (1) Epigastric/subxiphoidal transverse
view, (2) longitudinal pleural view right, (3) longitudinal right flank/
upper quadrant view, (4) longitudinal pleural view left, (5) longitudi-
nal left flank/upper quadrant view, and (6) transverse pelvic view
(adapted from Heller et al. 201211).
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FOCUSED ASSESSMENT WITH SONOGRAPHY
FOR ECHINOCOCCOSIS
Cystic echinococcosis (CE) is highly prevalent in sheep farm-
ing areas, especially in central Asia, China, South America,
the Mediterranean, eastern Europe, and considerable parts of
Africa.29,30 In humans, CE cysts develop predominantly in the
liver (60–70%) and lungs (20–30%). On average, 60–75% of
infected patients with hepatic CE are asymptomatic.31 When
present, symptoms may be local (most commonly right upper
quadrant pain) or systemic (fever, jaundice, or allergic mani-
festations), due to mass effect, communication with hollow
structures, superinfection, or loss of integrity of the cyst’s wall.
Based on individual case reports, it has been hypothesized that
HIV may affect the course of CE and lead to unusual and
potentially more severe clinical disease.32
US is the technique of choice for abdominal CE diagnosis,
staging, and follow-up33 and enables US-assisted percutane-
ous therapeutic procedures. The different types of cysts can
be grouped according to the WHO-IWGE (Informal Work-
ing Group on Echinococcosis) classification, which is also the
basis of the stage-specific approach to the clinical manage-
ment of CE (Figure 3).34,35
Sonographic features of CE cysts are as follows35:
1. Double wall of the cyst, especially evident in fluid-filled
CE1 cysts.
2. “Water lily sign” of CE3a cysts, which reflects the
detached endocyst fluctuating in the cyst fluid content.
3. “Honeycomb appearance” of multivesiculated cysts (CE2
and CE3b), in which the impression of “septa” is formed
by the adjacent walls of daughter vesicles (CE2) or in
which daughter vesicles have formed in pseudo-solid,
hyperechoic, and nonhomogeneous cyst content (CE3b).
4. The “ball-of-wool” sign of CE4 cysts, characterized by the
appearance of hypoechoic, degenerating cyst membranes
folded inside pseudo-solid cyst content.
5. The wall calcification of cysts with pseudo-solid content
(CE5).
Key in the differentiation between CE1 and simple cysts is
the visualization of the double wall, which is absent in non-
parasitic cysts. Serology and, if necessary, US-guided aspira-
tion and microscopic analysis of the cyst content will further
aid the diagnosis.
US screening for hepatic CE has been conducted in many
endemic countries for years.36–40 For example, in Argentina,
a yearly 2-day “focused assessment with sonography for echi-
nococcosis” (FASE) training course has been implemented
since 2000, where general practitioners working in rural endemic
areas with no previous experience with US are trained in
FASE. Four standard images are acquired, and according to
results of scans and consultations with experts, patients are
offered stage-specific clinical management.36 Annual screening
of large populations and regular long-term follow-up of diag-
nosed cases without costly travel by the patients to tertiary
care facilities, as well as reduction in loss to follow-up, were
achieved. The repeated annual training ensures sustainability,
by compensating for the high turnover of general practitioners
in rural areas.
In other endemic settings, the implementation of short
protocols allowing the diagnosis and classification of CE
FIGURE 3. Suggested cystic echinococcosis (CE) stage-specific clinical management options according to World Health Organization Informal
Working Group on Echinococcosis (WHO-IWGE) Expert consensus.34 PAIR = puncture, aspiration, injection of a scolicidal agent, and re-aspiration.
Non-PAIR percutaneous treatments include several percutaneous techniques using cutting instruments and large bore catheters to evacuate the
entire cyst content.
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cysts according to the WHO-IWGE criteria could provide
the basis for early detection and clinical management of the
infection. As cysts of different stages show very different
responses to various management options,41–44 staging sup-
ported through remote advice by experts in treatment cen-
ters could be helpful.
OTHER INFECTIOUS DISEASES WITH POTENTIAL
FOR POCUS APPLICATION
Amebic liver abscess. Amebiasis is one of the most com-
mon parasitic diseases worldwide and is prevalent in all trop-
ical countries.45 Amebic liver abscess is more common in
adults than in children and more common in men than in
women. Patients usually present with fever, possibly right
upper quadrant pain and jaundice. The condition is well
suited for a POCUS approach.46
Sonographically, amebic liver abscess presents as a focal
hepatic lesion, which is single in 60% of cases and is most
commonly located in the posterior part of the right lobe
(Figure 4A). The amebic abscess is usually hypoechoic com-
pared with normal liver tissue, without an appreciable rim
or capsule. In the center or at the periphery of the amebic
abscess, hyperechoic areas may be seen. After anti-amebic
treatment,47 the lesion tends to become more hypoechoic and
the margins become better defined.48,49 Serology can support
the diagnosis when available; US-guided aspiration shows
material of necrotic hepatocytes (“anchovy sauce”) typical in
amebic abscesses. Diagnosis does usually not require aspira-
tion. The clinical and sonographic picture, in conjunction with
a history of possible exposure, is sufficient to start metronida-
zole treatment. Today, the indication for aspiration as diagnos-
tic or therapeutic intervention is mainly limited to cases with
an acute risk of rupture.50
The main clinical and sonographic differential diagnosis of
amebic liver abscess is pyogenic liver abscess (Figure 4B).
These are more commonly reported outside the tropics,
often in patients with risk factors, such as biliary tree infec-
tions, diverticulitis, and a history of abdominal intervention.
Although occasionally difficult to identify in the early stages,
because of similar echogenicity of the surrounding liver tis-
sue, pyogenic lesions eventually become hypoechoic com-
pared with liver and can be more variable in shape and often
have irregular walls. Pyogenic liver abscesses are also more
often multiple, involving both lobes of the liver, and some
show areas of marked echogenicity due to gas bubbles,
which are not a feature of amebic abscesses unless super-
infected. Treatment can be attempted with broad-spectrum
antibiotics covering gram-negative and anaerobic bacteria.
A few further etiologic infectious differentials of abscess-
like liver lesions need to be mentioned. If a central calcifica-
tion is visible within the abscess, Brucella infection should be
considered.51 Fasciola infection may present with hypoechoic
lesions, especially subcapsular, and forming linear “tracks”
through the liver.52 As with hepatic CE, other differential
diagnoses of focal liver lesions, infectious and noninfectious,
need to be considered.
Apart from individual case descriptions,46 no published
data on the use of POCUS to diagnose amebic and other
liver abscesses is available. POCUS protocols to screen the
liver using 3–4 scan positions, including an intercostal and
epigastric approach appear feasible, but will need validation
in further studies. Upon finding a characteristic lesion, anti-
biotic treatment may be started. However, if a liver lesion
does not show the typical, characteristic appearances of an
abscess or CE cyst for example, and the binary approach of
POCUS cannot be applied, the findings should be viewed
with caution and treatment decision should be guided by
clinical assessment. Referral for a formal US assessment or
other imaging, where available, should also be considered.
Schistosomiasis. Schistosomiasis is a waterborne helminthic
infection mainly affecting either the urogenital tract (Schistosoma
haematobium) or the gastrointestinal tract (Schistosoma
mansoni, Schistosoma japonicum). To a lesser extent, all can
affect the lung causing pulmonary hypertension.53 More than
250 million people are affected worldwide and there are more
than 200,000 deaths per year attributable to schistosomiasis
in sub-Saharan Africa.54
Schistosomiasis-associated morbidity is due to inflamma-
tion and consecutive fibrosis around entrapped eggs in the
tissues. This leads to progressive organ damage and failure.53
It is important to note that morbidity persists even after eggs
are no longer detectable in stool or urine. This highlights the
importance of early antihelminthic therapy to prevent and
reverse early fibrosis.55
Urogenital schistosomiasis. Urogenital infection is seen
mainly in sub-Saharan Africa, Egypt, and on the Arabian
Peninsula. Schistosoma haematobium adult worms mature
in the vesical plexus. The hallmark symptoms of urogenital
schistosomiasis are dysuria and hematuria; earlier symptoms,
FIGURE 4. (A) Right longitudinal upper quadrant view: amebic liver abscess posteriorly in the right lobe of the liver, presenting as a round
hypoechoic lesion with hyperechoic debris and without a clearly discernable wall. (B) Right longitudinal upper quadrant view: pyogenic liver
abscess presenting as an irregularly shaped, hypo- to anechoic lesion, containing hyperechoic gas bubbles with posterior acoustic shadowing.
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particularly in children, include fatigue and anemia.56 The
peak of morbidity is observed in children aged 7–14 years;
however, infection occurs as early as infancy in endemic areas.57
In longstanding infections, symptoms of urinary tract obstruc-
tion and kidney failure are seen, secondary to fibrosis of
bladder and ureter. Squamous cell carcinoma of the bladder
is a possible late complication.
Fibrotic changes of the urinary tract because of schistoso-
miasis can easily be identified by US,58 and findings are
described in WHO guidelines for identification and reporting
of schistosomiasis.59 Bladder wall thickening and intravesical
masses are common observations; in advanced disease, upper
urinary tract obstruction is characterized by dilatation of the
renal pelvis (Figure 5).
US in urinary schistosomiasis has been reported to be an
“simple-to-learn” examination.60 In support of this assertion,
the detection of urinary tract dilatation (e.g., as a conse-
quence of urolithiasis) is commonly taught in POCUS
courses in EM for the evaluation of flank pain. A POCUS
protocol for urinary schistosomiasis using the lateral abdomi-
nal scans to visualize the kidneys, and a pelvic scan for the
bladder could be developed and studied for clinical feasibil-
ity and value. As schistosomiasis has a highly focal geograph-
ical distribution, it is important to identify endemic areas and
patient groups at risk. In former hyperendemic regions,
where control programs have reduced the prevalence of
infection, patients with low-intensity infection and sequelae
may still be found. Diagnosis may be missed if it is only
based on the detection of eggs in urine, as the egg excretion
does not necessarily correlate with egg entrapment. Patients
with urogenital schistosomiasis could therefore be identified
by suggestive POCUS and then treated with praziquantel.
Most bladder pathology regresses after treatment and can be
monitored by US. Urinary tract dilatation frequently persists
even in successfully treated patients.61 Non-resolving masses,
especially in adult patients, should be investigated further by
cystoscopy in view of the risk of bladder cancer.
Intestinal schistosomiasis. Although the highest prevalence
of S. mansoni infection leading to intestinal and hepatosplenic
disease is found in sub-Saharan Africa, cases are also encoun-
tered in the Caribbean and South America, mostly Brazil.
Schistosoma japonicum, affecting similar organs, remains
endemic in limited areas of China, the Philippines, and parts
of Indonesia.62 As S. mansoni adult worms mature in the por-
tal vein, schistosomiasis-associated morbidity develops as eggs
become entrapped in the tissues (bowel wall and periportal
area) causing initial inflammation and subsequent fibrosis.
Liver changes evolve from mild to severe periportal fibrotic
changes with preservation of parenchyma until the final stages.
Reactive splenic hyperplasia and portal hypertension ensue
and dire downstream consequences include death from bleed-
ing of esophageal varices.63
The diagnostic sonographic liver features, such as echogenic
rings or streaks around the portal venous branches and
echogenic bands extending from the main portal vein to the
liver surface, are well described; various fibrosis patterns are
summarized in a WHO report (Figure 6).59 In S. japonicum
infections, the additional finding of a network of fibrosis may
be seen, resulting in a so-called “tortoise back” appearance.59
The WHO patterns are well established and widely used.64
Focused US in intestinal schistosomiasis could be used for
different purposes depending on the stage of the disease: 1)
identifying early, potentially reversible fibrotic changes
(WHO patterns B–D) in patients (mostly children) from
endemic areas, who would benefit from medical treatment
with antiparasitic drugs (praziquantel) and 2) identifying
affected patients at imminent risk of bleeding (WHO patterns
E and F), who might benefit from endoscopy.
FIGURE 5. (A) Longitudinal pelvic view: thickened and irregular wall of the urinary bladder secondary to Schistosoma haematobium infection.
(B) Right longitudinal flank view: dilatation of the renal collecting system, secondary to fibrosis and obstruction in S. haematobium infection.
FIGURE 6. Epigastric transverse view: liver with bright hyper-
echoic fibrosis surrounding the intrahepatic portal vessels, due to
Schistosoma mansoni.
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WHO patterns B–D, representing patients with mild liver
fibrosis, are not pathognomonic and can be difficult to differ-
entiate from normal liver or other disease etiologies.65 The
interobserver agreement has been found to be low, especially
for mild cases.66 Without the US imaging experience needed
to subcategorize these patients accurately, misdiagnosis of
milder cases of intestinal schistosomiasis can easily occur.
Patients with image pattern B and C rarely need endoscopy
as their risk of bleeding is low. However, in endemic areas,
those patients could benefit from early treatment that poten-
tially slows down the development of ongoing disease, and
reverses early fibrosis.
US can reliably visualize significant hepatic fibrosis (WHO
patterns E and F), which is helpful in identifying patients
with clinically advanced disease. These patients are at higher
risk of variceal bleeding67 and should undergo endoscopy if
possible. The patient’s risk for variceal bleeding increases
when portal hypertension is present. Sonographic changes
suggestive of portal hypertension are an increased diameter
of the portal vein (normally < 12 mm in adults) or splenic
vein (normally < 9 mm),68 the presence of ascites, and the
development of portosystemic collateral vessels.59 The most
commonly described collateral veins are the perigastric, the
paraumbilical, and the splenorenal veins. Detection is
increased by color Doppler, which also allows detection of
hepatofugal circulation.68 Enlargement of the caudate lobe
compared with the right lobe is another finding, which is rel-
atively easy to visualize by US, and reflects changes in portal
blood supply in the cirrhotic liver. Caudate lobe enlargement
has been described in patients with schistosomiasis.69 Spleno-
megaly can also be a sign of portal hypertension, and in
schistosomiasis, the spleen may show multiple nonspecific
tiny echogenic foci (Gamna–Gandy bodies).70 The size of the
spleen is easy to assess; however, possible alternative diagno-
ses such as chronic splenomegaly in areas hyperendemic for
malaria, visceral leishmaniasis (VL), or chronic HIV infection
reduce its entity-specific diagnostic value in the absence of
collaterals. When signs of portal hypertension are present,
patients should undergo endoscopy whenever possible even if
they only show milder forms of periportal fibrosis (pattern D).
For busy clinicians, the entire WHO protocol, including
multiple measurements, might be too complicated and time
consuming. A simplified POCUS protocol applying a few
standardized liver views could be devised to identify patients
with hepatosplenic involvement in intestinal schistosomiasis
and to identify in particular those patients at risk of variceal
bleeding. The results would guide management decisions:
antihelminthic treatment47 and sonographic follow-up for
mild cases and antihelminthic treatment and referral to a ter-
tiary center with capacity to perform endoscopic sclerother-
apy for severe cases.
Lymphatic filariasis. Lymphatic filariasis, predominantly
caused by Wuchereria bancrofti, is a disfiguring and disabling
disease affecting an estimated 120 million people through-
out the tropics. The highest burden of pathology is born
by infected men showing hydrocele; another sign is lower
limb lymphedema.
US has proven particularly useful in detecting pathology
in male patients. So far, it has mainly been used to detect
moving worms in supratesticular lymphatic vessels of infected
men participating in clinical trials (the so-called “filarial dance
sign”). Worm nest finding in women may also be possible,
although less frequently documented.71 Large volume hydro-
cele in males, hyperechoic appearance of scrotal fluid, and
presence of lymph scrotum (thickened scrotal skin > 0.45 cm,
porous and wart like skin appearance, pain attacks, and leak-
age of lymph fluid) are associated with increased risk of testic-
ular inflammation and necrosis (Figure 7).72 Recently, it has
been reported that 56% of examined males in an endemic
area in Ghana presented with hydroceles of variable degree
and 9% showed echodense fluid,73 suggesting a considerable
proportion of patients to be at risk of testicular inflammation
and necrosis; the relative frequency of different “filaricele”
conditions is, however, unknown.
The use of POCUS approach beyond clinical trials for
management of individual patients has received much less
attention. Brief US protocols scanning the scrotum for
abovementioned signs could be useful in allocating patients
with hydrocele to high- or low-risk groups and to adapt the
therapeutic approach. Medical treatment with doxycycline
ameliorates lymphedema and hydrocele in infected patients
(i.e., with detectable filarial circulating antigens).74,75 Inter-
estingly, doxycycline treatment has also been found to ame-
liorate mild to moderate lymphedema in patients without
active infection (i.e., filarial antigen negative),76 but so far it
is unknown if this treatment is also effective in early stages
of hydrocele in patients without active infection. Surgical
programs for hydrocele due to lymphatic filariasis have been
FIGURE 7. (A) Longitudinal scan of hemiscrotum showing anechoic fluid hydrocele. (B) Longitudinal scan of hemiscrotum showing low-
intensity echoes in hydrocele fluid and thickened scrotal skin.
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launched,77 and it is crucial to identify patients at high risk
of scrotal complications for referral to surgery. POCUS could
play a decisive role in this identification.
Visceral Leishmaniasis. Each year, an estimated 500,000
new patients suffer from VL caused by many different spe-
cies of Leishmania; the disease burden is particularly high on
the Indian subcontinent and in east Africa.78 Patients present
with fever, cough, abdominal pain, diarrhea, wasting, and pan-
cytopenia. US consistently reveals hepatosplenomegaly, and,
in a large proportion of cases, abdominal lymphadenopa-
thy.79,80 In recent reports, nodular changes in the spleen have
been reported, particularly in children81 but also in adults.82
Whether these US findings, which could be incorporated
into a POCUS protocol, could help with the diagnosis or
follow-up of VL and/or with the differential diagnosis between
TB and VL in coendemic areas, remains to be studied. The
hardest-hit regions (southern Sudan; Bihar State, India) would
be locations where such POCUS protocols could be of value
and where studies of the validity of such POCUS protocols
could be conducted.
Viral hemorrhagic fever. Viral hemorrhagic fevers (VHFs)
are caused by a variety of viruses (Arenaviridae, Filoviridae,
Bunyaviridae, Flaviviridae, and Rhabdoviridae). Worldwide,
dengue virus is the most common VHF, but in specific geo-
graphic areas other viruses such as Crimean–Congo hemor-
rhagic fever (CCHF) virus may be also prevalent. Because of
the large-scale outbreak in west Africa in 2014 and its high
mortality rate,83 the Ebola virus has recently gained much
importance. Clinically, VHF infections present with fever,
headache and muscle pain, rashes, and abdominal symptoms.
On progression, hemorrhagic phenomena such as thrombo-
cytopenia, bruises, and internal bleeding occur, which may
be followed by shock and death.
Effusions detected by US (pleural, pericardial, and ascitic)
have been described as signs of plasma leakage in children84
and adults85 with dengue infection. The presence of effusions
correlated with progression to more severe forms of the dis-
ease (dengue hemorrhagic fever (DHF), dengue shock syn-
drome), and its negative predictive value was found to be
very high.85 Gallbladder wall thickening85,86 and subcapsular
splenic and hepatic fluid collections87 have also been reported
as signs of plasma leakage. It has been suggested that during
a dengue epidemic, the diagnosis of DHF should be consid-
ered when US demonstrates gallbladder wall thickening,
ascites, splenomegaly, and pleural effusion in a febrile patient
with thrombocytopenia.88
Similarly, in a multivariate analysis in CCHF, gallbladder
wall thickening, and intra-abdominal fluid collections were
found to be significantly associated with disease severity.89,90
Validation of a standardized POCUS protocol to diagnose
and predict severity of VHF in epidemic situations and to
adapt monitoring and supportive treatment accordingly
appears worthwhile.
Beside the potential predictive value for severity assess-
ment in VHF, US can be used to determine hemodynamic
parameters in patients with VHF. POCUS is well established
in the care of critically ill patients for the assessment of the
filling status of the inferior vena cava and the left ventricle.91
Intercostal scanning of the lung can show suggestive signs of
interstitial pulmonary edema, and thus guide fluid adminis-
tration.92 This is particularly helpful in patients with highly
contagious VHF as other forms of physical examination such
as auscultation may be hindered by isolation measures and
protective equipment. A preliminary report on the use of US
in patients infected with Ebola virus supports these indica-
tions and suggests the use of focused POCUS done by infec-
tious disease clinicians trained in isolation measures and in
relevant POCUS protocols.93 Small mobile US equipment
should remain in the isolation unit to prevent spread of
the infection.
MISCELLANEOUS INFECTIOUS DISEASES
The potential value of US in supporting diagnosis and
management of a range of other infectious diseases in tropi-
cal areas and beyond appears huge and increasing. Varying
experience with US for assessment of infectious diseases has
been reported and some are mentioned in brief below. The
suitability and value of POCUS protocols in these diseases
remains to be studied. Diagnostic usefulness of US in infec-
tions caused by flukes other than Schistosoma spp. has been
reported for fascioliasis-related hepatic and biliary dis-
ease,52,94,95 pulmonary and abdominal paragonimiasis,96 and
clonorchiasis.97 Other helminthic infections for which US has
been used include onchocerciasis,98–100 abdominal and ocular
toxocariasis,101,102 and ascariasis and its complications such
as bile duct invasion.103–105 Further parasitic diseases for
which experimental US experience is available include Chagas
disease,106 myiasis,106,107 and even malaria.108 The usefulness
of POCUS in bacterial infectious diseases has recently been
reviewed, describing differentiation between cellulitis and
abscesses, diagnosis of septic arthritis, identifying underlying
causes of sepsis, and pneumonia.109 Further US applications
have been reported for leprosy,110,111 rheumatic heart disease
as sequelae of Streptococcus pyogenes infection,112 myce-
toma,105 and opportunistic infections in patients living with
HIV.113,114 With US getting closer to the point of care and
into the hands of treating physicians, its use in infectious dis-
eases may increase, and further POCUS indications may
become established.
TECHNICAL AND TRAINING REQUIREMENTS
Technical. Technical requirements for POCUS equipment
are relatively basic. Most commercially available machines
can be used.
The size of the device plays an important role when mobile
scanning is intended.
The availability of electricity and US gel needs to be consid-
ered in remote settings, and a voltage stabilizer may be
required in a situation where voltage peaks put the
machine at risk of damage.
In many places, only gray-scale (“black and white”) scanners
will be available, which can perfectly serve the purpose.
The additional availability of color Doppler on the scan-
ner is helpful to identify blood flow. It will, for example,
be helpful to find collaterals in abdominal schistosomiasis,
but also be of value in identifying vessels in other anatomical
regions. It does, however, significantly increase the cost of
the equipment.
To facilitate web-based, remote review and support, an option
to extract digital images and video clips onto an external
storage device is highly desirable.
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The final choice of equipment will mainly depend on local
availability and maintenance provision. Obviously, the
available budget plays a substantial role, but cost of equip-
ment has come down significantly in recent years, improv-
ing affordability.
Training. US is a highly operator-dependent tool, which can
easily lead to misdiagnosis if implemented inappropriately
and without adequate training. The WHO scientific Group on
Clinical Diagnostic Imaging concluded that “. . . more impor-
tant than the equipment is the availability of skills. . ..”115 For
comprehensive US use, the WHO recommends that physi-
cians should undergo training over 3–6 months, including
300–500 examinations. However, these formal training pro-
grams, while ideal, are often too time consuming to achieve
meaningful coverage in resource-limited settings. In the
absence of formally trained sonographers or radiologists, US
training should be aimed at health-care professionals, espe-
cially those working on the front line. In particular, this means
general physicians and clinical officers in district hospitals and
clinics who have little or no experience with imaging technol-
ogy and who cannot afford to be away from their clinical
duties for a long training course. Focused POCUS applica-
tions do not require as much training, and thus allow a degree
of flexibility. If physicians could be trained in short courses,
which will reduce their absence from clinical duties, while pro-
viding them with the most relevant US skills,10 this would
widen access to this very useful diagnostic modality.
Short courses have been reported to be sufficient to teach
POCUS modules.116 Regular, short US courses with a focus
on infectious diseases are held in Pavia, Italy,117 in Lima,
Peru,118 and previously in Liverpool, United Kingdom.119
However, the great advantage of courses held directly in
low-resource settings is that they will allow local physicians
to participate without excessive travel expenses or lengthy
leave of absence. In addition, this allows for more rapid
and relevant learning, as infection-specific pathologic find-
ings are more prevalent in endemic areas. Short training
courses have been reported from various sites in resource-
limited settings.9,120–122 However, there has been neither wide-
spread dissemination nor standardization of these training
initiatives nor robust validation, particularly in terms of the
operator’s maintenance of adequate technical ability in the
long term.
In addition, there is no literature available on how many
exams are needed to achieve competency in US skills for cli-
nicians in developing countries. However, in industrialized
countries, figures of approximately 30–40 supervised exami-
nations are consistently reported in the literature to master
one particular POCUS protocol. For example, 40 exams are
reportedly necessary to accurately detect intrauterine first
trimester pregnancy and complications,123 while only 30 may
be needed to learn how to detect hydronephrosis.124 As it
has become apparent that some operators acquire skills
more rapidly than others, there is an increasing move toward
uniform, cross-specialty competency-based assessment, which
may be of benefit when designing future courses.125
As external trainers are often only available for short
periods, other methods to ensure continuous support and
quality assurance need to be considered. With increasing
availability of internet access and faster connections in geo-
graphically remote settings, the application of telemedicine
solutions could be expanded to support practitioners in areas
where direct supervision is scarce or absent. Recently, the
feasibility of a tele-US system using Skype™ (Luxembourg,
Luxembourg) and cheap, widely available, consumer electron-
ics equipment, was successfully piloted for remote supervision
of FASH exams in Lambaréné, Gabon.12 Another, even eas-
ier, option is the extraction of digital images and video clips
that can then be sent via secure telemedicine servers for
review and second opinion.
A number of introductory texts covering the use of US in
infectious diseases exist.126–128 All are specifically aimed at phy-
sicians with limited imaging experience working in resource-
limited settings and are available free or at low cost.
Several associations such as the American College of Emer-
gency Physicians129 endorse the approach of focused US
exams. A section of the International Federation for Emer-
gency Medicine has recently developed a consensus document
drawing on regional and national guideline standards and
training requirements to summarize recommendations for an
appropriate level of training that will allow for the provision
of a safe and effective US service.130 Analogous to these rec-
ommendations, the development of standardized training and
practice guidelines for POCUS courses in the field of infec-
tious diseases, based on previous experience and available
training material, is a key priority in the field. Recommenda-
tions and standards, building on those existing for EM US,
should be created. In our opinion, a modular approach
consisting of theoretical and practical sessions would be feasi-
ble. Initially, protocols and questions, which are easier to mas-
ter, such as FASH or the detection of urinary tract changes in
schistosomiasis can be taught. Once the trainee gains experi-
ence in the technology of US, technically more demanding
topics such as liver POCUS, echinococcal cyst morphology,
and even the assessment of collateral vessels may be taught in
further modules. A rigorous evaluation of these training
methods is highly desired, but unfortunately not yet available.
Modular training could facilitate the availability and acceler-
ate the spread of POCUS.
CONCLUSIONS
US is a powerful diagnostic tool, which has become increas-
ingly available and affordable. From the aforementioned
considerations and our own clinical experience, we are of
the opinion that POCUS is ideally suited to the diagnosis
of several infectious conditions in resource-limited settings
(Table 1). We believe that focused, high-quality training will
be the key to the successful expansion of US applications. To
facilitate this, standardized protocols and training curricula that
enable health-care workers to answer dedicated, “focused”
questions need to be developed and validated in the field.
Using the focused approach will make US diagnosis avail-
able to patients who would otherwise have very limited or
no access to medical imaging.
Received June 8, 2015. Accepted for publication August 18, 2015.
Published online September 28, 2015.
Authors’ addresses: Sabine Bélard, Department of Pediatric Pneu-
mology and Immunology, Charité Universitätsmedizin Berlin, Berlin,
Germany, E-mail: sabine.belard@charite.de. Francesca Tamarozzi,
Department of Clinical, Surgical, Diagnostic and Pediatric Sciences,
University of Pavia, Pavia, Italy, E-mail: f_tamarozzi@yahoo.com.
17POINT-OF-CARE ULTRASOUND IN TROPICAL MEDICINE
Amaya L. Bustinduy, Paediatric Infectious Diseases Research Group,
Institute of Infection and Immunity, St. George’s University of London,
United Kingdom, E-mail: bustinji06@gmail.com. Claudia Wallrauch,
Department of Medicine, Klinikum Muenchen-Perlach, Munich,
Germany, E-mail: claudiawallrauch@web.de. Martin P. Grobusch
and Tom Heller, Center of Tropical Medicine and Travel Medicine,
Department of Infectious Diseases, Division of Internal Medicine,
Academic Medical Center, University of Amsterdam, Amsterdam,
The Netherlands, E-mails: m.p.grobusch@amc.uva.nl and echnatom@
web.de. Walter Kuhn, Emergency Medicine, Medical College of
Georgia, Georgia Regents University, Augusta, GA, E-mail: tkuhn@
gru.edu. Enrico Brunetti, Division of Infectious and Tropical Diseases,
University of Pavia/IRCCS San Matteo Hospital Foundation, Pavia,
Italy, E-mail: enrico.brunetti@unipv.it. Elizabeth Joekes, Department
of Radiology, Liverpool School of Tropical Medicine, Liverpool,
United Kingdom, E-mail: e.joekes@liverpool.ac.uk.
REFERENCES
1. Richter J, Hatz C, Haussinger D, 2003. Ultrasound in tropical
and parasitic diseases. Lancet 362: 900–902.
2. Moore CL, Copel JA, 2011. Point-of-care ultrasonography.
N Engl J Med 364: 749–757.
3. Hanscheid T, Rebelo M, Grobusch MP, 2014. Point-of-care
tests: where is the point? Lancet 14: 922.
4. Ma OJ, Mateer JR, Ogata M, Kefer MP, Wittmann D,
Aprahamian C, 1995. Prospective analysis of a rapid trauma
ultrasound examination performed by emergency physicians.
J Trauma 38: 879–885.
5. Mateer J, Plummer D, Heller M, Olson D, Jehle D, Overton D,
Gussow L, 1994. Model curriculum for physician training in
emergency ultrasonography. Ann Emerg Med 23: 95–102.
6. American Institute of Ultrasound in Medicine, 2014. AIUM
practice guideline for the performance of the focused assess-
ment with sonography for trauma (FAST) examination.
J Ultrasound Med 33: 2047–2056.
7. Mohammad A, Hefny AF, Abu-Zidan FM, 2014. Focused
Assessment Sonography for Trauma (FAST) training: a sys-
tematic review. World J Surg 38: 1009–1018.
8. Brunetti E, 2013. Ultrasound in tropical medicine. Farrar J,
Junghanss T, Kang G, Lalloo D, White NJ, eds. Manson’s
Tropical Diseases, 23rd edition. Endinburgh, United Kingdom:
Elsevier, 60–67.
9. Shah S, Noble VE, Umulisa I, Dushimiyimana JM, Bukhman
G, Mukherjee J, Rich M, Epino H, 2008. Development of an
ultrasound training curriculum in a limited resource interna-
tional setting: successes and challenges of ultrasound training
in rural Rwanda. Int J Emerg Med 1: 193–196.
10. Maru DS, Schwarz R, Jason A, Basu S, Sharma A, Moore C,
2010. Turning a blind eye: the mobilization of radiology ser-
vices in resource-poor regions. Global Health 6: 18.
11. Heller T, Wallrauch C, Goblirsch S, Brunetti E, 2012. Focused
assessment with sonography for HIV-associated tuberculosis
(FASH): a short protocol and a pictorial review. Crit Ultrasound
J 4: 21.
12. Janssen S, Grobusch MP, Heller T, 2013. ‘Remote FASH’ tele-
sonography—a novel tool to assist diagnosing HIV-associated
extrapulmonary tuberculosis in remote areas. Acta Trop 127:
53–55.
13. Heller T, Goblirsch S, Bahlas S, Ahmed M, Giordani MT,
Wallrauch C, Brunetti E, 2013. Diagnostic value of FASH
ultrasound and chest X-ray in HIV-co-infected patients with
abdominal tuberculosis. Int J Tuberc Lung Dis 17: 342–344.
14. Heller T, Wallrauch C, Brunetti E, Giordani MT, 2014.
Changes of FASH ultrasound findings in TB-HIV patients
during anti-tuberculosis treatment. Int J Tuberc Lung Dis 18:
837–839.
15. van Hoving DJ, Lamprecht HH, Stander M, Vallabh K,
Fredericks D, Louw P, Muller M, Malan JJ, 2013. Adequacy
of the emergency point-of-care ultrasound core curriculum for
the local burden of disease in South Africa. Emerg Med J
30: 312–315.
16. Belard S, Heller T, Grobusch MP, Zar HJ, 2014. Point-of-care
ultrasound: a simple protocol to improve diagnosis of child-
hood tuberculosis. Pediatr Radiol 44: 679–680.
17. WHO, 2014. Global Tuberculosis Report 2014. Available at:
http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_
eng.pdf?ua=1. Accessed May 29, 2015.
18. von Reyn CF, Kimambo S, Mtei L, Arbeit RD, Maro I, Bakari
M, Matee M, Lahey T, Adams LV, Black W, Mackenzie T,
Lyimo J, Tvaroha S, Waddell R, Kreiswirth B, Horsburgh
CR, Pallangyo K, 2011. Disseminated tuberculosis in human
immunodeficiency virus infection: ineffective immunity, poly-
clonal disease and high mortality. Int J Tuberc Lung Dis 15:
1087–1092.
19. WHO, 2006. Improving the Diagnosis and Treatment of Smear-
Negative Pulmonary and Extrapulmonary Tuberculosis among
Adults and Adolescents: Recommendations for HIV-Prevalent
and Resource-Constrained Settings. Available at: http://www
.who.int/tb/publications/2006/tbhiv_recommendations.pdf. Accessed
May 17, 2015.
20. Luzze H, Elliott AM, Joloba ML, Odida M, Oweka-Onyee J,
Nakiyingi J, Quigley M, Hirsch C, Mugerwa RD, Okwera A,
Johnson JL, 2001. Evaluation of suspected tuberculous pleu-
risy: clinical and diagnostic findings in HIV-1-positive and HIV-
negative adults in Uganda. Int J Tuberc Lung Dis 5: 746–753.
21. Reuter H, Burgess LJ, Doubell AF, 2005. Epidemiology of peri-
cardial effusions at a large academic hospital in South Africa.
Epidemiol Infect 133: 393–399.
22. Brindle HE, Allain TJ, Kampondeni S, Kayange N, Faragher B,
Bates I, Joekes E, 2013. Utilization of ultrasound in medical
inpatients in Malawi. Trans R Soc Trop Med Hyg 107: 405–410.
23. Heller T, Lessells RJ, Wallrauch C, Brunetti E, 2010. Tubercu-
losis pericarditis with cardiac tamponade: management in the
resource-limited setting. Am J Trop Med Hyg 83: 1311–1314.
24. Giordani MT, Brunetti E, Binazzi R, Benedetti P, Stecca C,
Goblirsch S, Heller T, 2012. Extrapulmonary mycobacterial
infections in a cohort of HIV-positive patients: ultrasound
experience from Vicenza, Italy. Infection 41: 409–414.
25. Heller T, Wallrauch C, Lessells RJ, Goblirsch S, Brunetti E,
2010. Short course for focused assessment with sonography
for human immunodeficiency virus/tuberculosis: preliminary
results in a rural setting in South Africa with high prevalence
of human immunodeficiency virus and tuberculosis. Am J
Trop Med Hyg 82: 512–515.
26. Ma OJ, Mateer JR, 1997. Trauma ultrasound examination
versus chest radiography in the detection of hemothorax.
Ann Emerg Med 29: 312–315, discussion 315–316.
27. Rozycki GS, Feliciano DV, Ochsner MG, Knudson MM, Hoyt
DB, Davis F, Hammerman D, Figueredo V, Harviel JD, Han
DC, Schmidt JA, 1999. The role of ultrasound in patients
with possible penetrating cardiac wounds: a prospective multi-
center study. J Trauma 46: 543–551, discussion 551–552.
28. Heller T, Goblirsch S, Wallrauch C, Lessells R, Brunetti E,
2010. Abdominal tuberculosis: sonographic diagnosis and
treatment response in HIV-positive adults in rural South
Africa. Int J Infect Dis 14 (Suppl 3): e108–e112.
29. Eckert J, Deplazes P, 2004. Biological, epidemiological, and
clinical aspects of echinococcosis, a zoonosis of increasing
concern. Clin Microbiol Rev 17: 107–135.
30. Wahlers K, Menezes CN, Wong ML, Zeyhle E, Ahmed ME,
Ocaido M, Stijnis C, Romig T, Kern P, Grobusch MP, 2012. Cys-
tic echinococcosis in sub-Saharan Africa. Lancet 12: 871–880.
31. Eckert J, Gemmell M, Meslin F-X, Pawlowski Z, 2001. WHO/
OIE Manual on Echinococcosis in Humans and Animals: A
Public Health Problem of Global Concern. Geneva, Switzerland:
World Organisation for Animal Health (Office International
des Epizooties) and World Health Organization. Available
at: http://whqlibdoc.who.int/publications/2001/929044522X.pdf.
Accessed May 17, 2015.
32. Wahlers K, Menezes CN, Romig T, Kern P, Grobusch MP,
2013. Cystic echinococcosis in South Africa: the worst yet to
come? Acta Trop 128: 1–6.
33. Stojkovic M, Rosenberger K, Kauczor HU, Junghanss T, Hosch
W, 2012. Diagnosing and staging of cystic echinococcosis: how
do CT and MRI perform in comparison to ultrasound? PLoS
Negl Trop Dis 6: e1880.
34. Brunetti E, Kern P, Vuitton DA, 2010. Expert consensus for
the diagnosis and treatment of cystic and alveolar echinococ-
cosis in humans. Acta Trop 114: 1–16.
18 BÉLARD AND OTHERS
35. WHO-IWGE, 2003. International classification of ultrasound
images in cystic echinococcosis for application in clinical and
field epidemiological settings. Acta Trop 85: 253–261.
36. Del Carpio M, Mercapide CH, Salvitti JC, Uchiumi L, Sustercic
J, Panomarenko H, Moguilensky J, Herrero E, Talmon G,
Volpe M, Araya D, Mujica G, Calabro A, Mancini S, Chiosso
C, Labanchi JL, Saad R, Goblirsch S, Brunetti E, Larrieu E,
2012. Early diagnosis, treatment and follow-up of cystic echino-
coccosis in remote rural areas in Patagonia: impact of ultra-
sound training of non-specialists. PLoS Negl Trop Dis 6: e1444.
37. Li T, Ito A, Pengcuo R, Sako Y, Chen X, Qiu D, Xiao N, Craig
PS, 2011. Post-treatment follow-up study of abdominal cystic
echinococcosis in Tibetan communities of northwest Sichuan
Province, China. PLoS Negl Trop Dis 5: e1364.
38. Elmahdi IE, Ali QM, Magzoub MM, Ibrahim AM, Saad MB,
Romig T, 2004. Cystic echinococcosis of livestock and humans
in central Sudan. Ann Trop Med Parasitol 98: 473–479.
39. Macpherson CN, Kachani M, Lyagoubi M, Berrada M, Shepherd
M, Fields PF, El Hasnaoui M, 2004. Cystic echinococcosis in
the Berber of the Mid Atlas mountains, Morocco: new insights
into the natural history of the disease in humans. Ann Trop
Med Parasitol 98: 481–490.
40. Muhtarov M, 2014. First portable ultrasound based screening
study in Bulgaria on the prevalence of cystic echinococcosis
in Kardzhali district. Trakia J Sci 12 (Suppl 1): 170–174.
41. Stojkovic M, Zwahlen M, Teggi A, Vutova K, Cretu CM, Virdone
R, Nicolaidou P, Cobanoglu N, Junghanss T, 2009. Treatment
response of cystic echinococcosis to benzimidazoles: a system-
atic review. PLoS Negl Trop Dis 3: e524.
42. Rinaldi F, De Silvestri A, Tamarozzi F, Cattaneo F, Lissandrin
R, Brunetti E, 2014. Medical treatment versus “Watch and
Wait” in the clinical management of CE3b echinococcal cysts
of the liver. BMC Infect Dis 14: 492.
43. Piccoli L, Tamarozzi F, Cattaneo F, Mariconti M, Filice C,
Bruno A, Brunetti E, 2014. Long-term sonographic and sero-
logical follow-up of inactive echinococcal cysts of the liver: hints
for a “watch-and-wait” approach. PLoS Negl Trop Dis 8: e3057.
44. Golemanov B, Grigorov N, Mitova R, Genov J, Vuchev D,
Tamarozzi F, Brunetti E, 2011. Efficacy and safety of PAIR
for cystic echinococcosis: experience on a large series of
patients from Bulgaria. Am J Trop Med Hyg 84: 48–51.
45. Stanley SL Jr, 2003. Amoebiasis. Lancet 361: 1025–1034.
46. Elia F, Campagnaro T, Salacone P, Casalis S, 2011. Goal-
directed ultrasound in a limited resource healthcare setting
and developing country. Crit Ultrasound J 3: 51–53.
47. The Medical Letter, 2013. Drugs for parasitic infections. Treat
Guidel Med Lett 11 (Suppl): e1–e31.
48. Stoopen M, Kimura K, 1989. Amebiasis. The technology of the
80’s. I. Ultrasound, computerized tomography and magnetic
resonance: have they helped improve the diagnosis of hepatic
abscess?. Rev Gastroenterol Mex 54: 167–175.
49. Mortele KJ, Segatto E, Ros PR, 2004. The infected liver:
radiologic-pathologic correlation. Radiographics 24: 937–955.
50. Weinke T, Grobusch MP, Guthoff W, 2002. Amebic liver
abscess—rare need for percutaneous treatment modalities.
Eur J Med Res 7: 25–29.
51. Heller T, Bélard S, Wallrauch C, Carretto E, Lissandrin R,
Filice C, Brunetti E, 2015. Patterns of hepatosplenic Brucella
abscesses on cross-sectional imaging. Am J Trop Med Hyg
93: 761–766.
52. Kabaalioglu A, Ceken K, Alimoglu E, Saba R, Cubuk M,
Arslan G, Apaydin A, 2007. Hepatobiliary fascioliasis: sono-
graphic and CT findings in 87 patients during the initial phase
and long-term follow-up. Am J Roentgenol 189: 824–828.
53. Colley DG, Bustinduy AL, Secor WE, King CH, 2014. Human
schistosomiasis. Lancet 383: 2253–2264.
54. WHO, 2015. Schistosomiasis. Available at: http://www.who
.int/schistosomiasis/epidemiology/en/. Accessed May 29 2015.
55. King CH, 2006. Long-term outcomes of school-based treatment
for control of urinary schistosomiasis: a review of experience in
Coast Province, Kenya. Mem Inst Oswaldo Cruz 101 (Suppl 1):
299–306.
56. Bustinduy AL, Parraga IM, Thomas CL, Mungai PL, Mutuku
F, Muchiri EM, Kitron U, King CH, 2013. Impact of poly-
parasitic infections on anemia and undernutrition among Kenyan
children living in a Schistosoma haematobium-endemic area.
Am J Trop Med Hyg 88: 433–440.
57. Stothard JR, Sousa-Figueiredo JC, Betson M, Bustinduy A,
Reinhard-Rupp J, 2013. Schistosomiasis in African infants and
preschool children: let them now be treated! Trends Parasitol
29: 197–205.
58. King CH, 2002. Ultrasound monitoring of structural urinary
tract disease in Schistosoma haematobium infection. Mem Inst
Oswaldo Cruz 97 (Suppl 1): 149–152.
59. Richter J, Hatz C, Campagne G, Bergquist N, Jenkins J, 2000.
Ultrasound in Schistosomiasis—A Practical Guide to the
Standardized Use of Ultrasonography for the Assessment of
Schistosomiasis-Related Morbidity. Available at: http://www
.who.int/tdr/publications/documents/ultrasound-schistosomiasis
.pdf. Accessed May 17, 2015.
60. Bonnard P, Boutouaba S, Diakhate I, Seck M, Dompnier JP,
Riveau G, 2011. Learning curve of vesico-urinary ultraso-
nography in Schistosoma haematobium infection with WHO
practical guide: a “simple to learn” examination. Am J Trop
Med Hyg 85: 1071–1074.
61. Wagatsuma Y, Aryeetey ME, Sack DA, Morrow RH, Hatz C,
Kojima S, 1999. Resolution and resurgence of Schistosoma
haematobium-induced pathology after community-based che-
motherapy in Ghana, as detected by ultrasound. J Infect Dis
179: 1515–1522.
62. WHO, 2015. Health Topics: Schistosomiasis. Available at: http://
www.who.int/topics/schistosomiasis/en/. Accessed May 27, 2015.
63. Bustinduy A, King CH, 2013. Schistosomiasis. Farrar J, Hotez
PJ, Junghanss T, Kang G, Lalloo D, White NJ, eds. Manson’s
Tropical Diseases, 23rd edition. Edinburgh, United Kingdom:
Elsevier.
64. el Scheich T, Holtfreter MC, Ekamp H, Singh DD, Mota R,
Hatz C, Richter J, 2014. The WHO ultrasonography protocol
for assessing hepatic morbidity due to Schistosoma mansoni.
Acceptance and evolution over 12 years. Parasitol Res 113:
3915–3925.
65. Ruiz-Guevara R, de Noya BA, Valero SK, Lecuna P, Garassini
M, Noya O, 2007. Clinical and ultrasound findings before and
after praziquantel treatment among Venezuelan schistosomia-
sis patients. Rev Soc Bras Med Trop 40: 505–511.
66. King CH, Magak P, Salam EA, Ouma JH, Kariuki HC, Blanton
RE, 2003. Measuring morbidity in schistosomiasis mansoni:
relationship between image pattern, portal vein diameter and
portal branch thickness in large-scale surveys using new
WHO coding guidelines for ultrasound in schistosomiasis.
Trop Med Int Health 8: 109–117.
67. Richter J, Correia Dacal AR, Vergetti Siqueira JG, Poggensee
G, Mannsmann U, Deelder A, Feldmeier H, 1998. Sono-
graphic prediction of variceal bleeding in patients with liver
fibrosis due to Schistosoma mansoni. Trop Med Int Health
3: 728–735.
68. Pinto-Silva RA, Queiroz LC, Azeredo LM, Silva LC,
Lambertucci JR, 2010. Ultrasound in schistosomiasis mansoni.
Mem Inst Oswaldo Cruz 105: 479–484.
69. Abdalla Balla E, Abdalla Abdo M, Ayad C, 2013. Evaluation
of caudate and right hepatic lobes ratio in patients with
Schistosoma mansoni using ultrasound in Al-Fao area. Indian
J Soc Res 4: 11.
70. Gonzalez TD, Santos JEM, Sales DM, Takemoto K,
Capobianco J, Brant PE, Colleoni R, Ahmed M, D’Ippolito
G, 2008. Ultrasonographic assessment of splenic siderotic
nodules in schistosomal patients with portal hypertension.
Radiol Bras 41: 69–73.
71. Mand S, Debrah A, Batsa L, Adjei O, Hoerauf A, 2004. Reli-
able and frequent detection of adult Wuchereria bancrofti
in Ghanaian women by ultrasonography. Trop Med Int Health
9: 1111–1114.
72. DeVries CR, 2002. The role of the urologist in the treatment
and elimination of lymphatic filariasis worldwide. BJU Int
89 (Suppl 1): 37–43.
73. Mand S, Debrah AY, Klarmann U, Mante S, Kwarteng A,
Batsa L, Marfo-Debrekyei Y, Adjei O, Hoerauf A, 2011. The
role of ultrasonography in the differentiation of the various
types of filaricele due to bancroftian filariasis. Acta Trop 120
(Suppl 1): S23–S32.
19POINT-OF-CARE ULTRASOUND IN TROPICAL MEDICINE
74. Debrah AY, Mand S, Specht S, Marfo-Debrekyei Y, Batsa L,
Pfarr K, Larbi J, Lawson B, Taylor M, Adjei O, Hoerauf A,
2006. Doxycycline reduces plasma VEGF-C/sVEGFR-3 and
improves pathology in lymphatic filariasis. PLoS Pathog 2: e92.
75. Debrah AY, Mand S, Marfo-Debrekyei Y, Batsa L, Pfarr K,
Lawson B, Taylor M, Adjei O, Hoerauf A, 2009. Reduction in
levels of plasma vascular endothelial growth factor-A and
improvement in hydrocele patients by targeting endosymbiotic
Wolbachia sp. in Wuchereria bancrofti with doxycycline. Am J
Trop Med Hyg 80: 956–963.
76. Mand S, Debrah AY, Klarmann U, Batsa L, Marfo-Debrekyei Y,
Kwarteng A, Specht S, Belda-Domene A, Fimmers R, Taylor
M, Adjei O, Hoerauf A, 2012. Doxycycline improves filarial
lymphedema independent of active filarial infection: a random-
ized controlled trial. Clin Infect Dis 55: 621–630.
77. WHO, 2002. Surgical Approaches to the Urogenital Manifesta-
tions of Lymphatic Filariasis. Available at: http://whqlibdoc
.who.int/hq/2002/WHO_CDS_CPE_CEE_2002.33.pdf?ua=1.
Accessed May 17, 2015.
78. Guerin PJ, Olliaro P, Sundar S, Boelaert M, Croft SL, Desjeux
P, Wasunna MK, Bryceson AD, 2002. Visceral leishmaniasis:
current status of control, diagnosis, and treatment, and a pro-
posed research and development agenda. Lancet 2: 494–501.
79. Mahmoud M, 2014. Assessment of visceral leishmaniasis con-
sequences using ultrasound. Open J Radiol 4: 201–206.
80. Abdalla E, Ayad C, Fadl A, ElGaddal A, Saeed A, 2014. Ultra-
sound findings in patients with visceral leishmaniasis. Int J
Med Imaging 2: 5–9.
81. Melchionda F, Varani S, Carfagnini F, Belotti T, Di Muccio T,
Tigani R, Bergamaschi R, Pession A, 2014. Spleen nodules: a
potential hallmark of visceral leishmaniasis in young children.
BMC Infect Dis 14: 620.
82. Bukte Y, Nazaroglu H, Mete A, Yilmaz F, 2004. Visceral leish-
maniasis with multiple nodular lesions of the liver and spleen:
CT and sonographic findings. Abdom Imaging 29: 82–84.
83. Grobusch MP, Visser BJ, Boersma J, Huson M, Janssen S,
Greve P, Browne JL, Ende-Bouwman J, Ende J, Zwinkels N,
Huizenga E, Bree GJ, Stijnis C, Vugt M, Goorhuis A, 2015.
Ebola virus disease: basics the medical specialist should know.
Netherlands J Crit Care 22: 6–14.
84. Balasubramanian S, Janakiraman L, Kumar SS, Muralinath S,
Shivbalan S, 2006. A reappraisal of the criteria to diagnose
plasma leakage in dengue hemorrhagic fever. Indian Pediatr
43: 334–339.
85. Michels M, Sumardi U, de Mast Q, Jusuf H, Puspita M, Dewi
IM, Sinarta S, Alisjahbana B, van der Ven AJ, 2013. The pre-
dictive diagnostic value of serial daily bedside ultrasonogra-
phy for severe dengue in Indonesian adults. PLoS Negl Trop
Dis 7: e2277.
86. Srikiatkhachorn A, Krautrachue A, Ratanaprakarn W,
Wongtapradit L, Nithipanya N, Kalayanarooj S, Nisalak A,
Thomas SJ, Gibbons RV, Mammen MP Jr, Libraty DH, Ennis
FA, Rothman AL, Green S, 2007. Natural history of plasma
leakage in dengue hemorrhagic fever: a serial ultrasonographic
study. Pediatr Infect Dis J 26: 283–290, discussion 291–292.
87. Bharath Kumar Reddy KR, Laksmana RR, Veerappa BG,
Shivananda, 2013. Ultrasonography as a tool in predicting the
severity of dengue fever in children–a useful aid in a develop-
ing country. Pediatr Radiol 43: 971–977.
88. Oliveira R, Rios L, Branco M, Braga Junior L, Nascimento J,
Silva G, Bandeira K, 2010. Usefulness of ultrasonography in
children with suspected dengue hemorrhagic fever: a litera-
ture review. Radiol Bras 43: 401–407.
89. Tufan ZK, Yigit H, Kacar M, Bulut C, Canpolat G, Hatipoglu
CA, Kinikli S, Kosar P, Demiroz AP, 2014. Sonographic
findings in patients with Crimean-Congo hemorrhagic fever.
J Ultrasound Med 33: 1999–2003.
90. Ziraman I, Celikbas A, Ergonul O, Degirmenci T, Uyanik SA,
Koparal S, Dokuzoguz B, 2014. Crimean-Congo hemorrhagic
fever: aid of abdominal ultrasonography in prediction of
severity. Vector Borne Zoonotic Dis 14: 817–820.
91. Carr BG, Dean AJ, Everett WW, Ku BS, Mark DG, Okusanya
O, Horan AD, Gracias VH, 2007. Intensivist bedside ultra-
sound (INBU) for volume assessment in the intensive care
unit: a pilot study. J Trauma 63: 495–500, discussion 500–502.
92. Lichtenstein D, 2013. FALLS-protocol: lung ultrasound in hemo-
dynamic assessment of shock. Heart Lung Vessel 5: 142–147.
93. Moreno CC, Kraft CS, Vanairsdale S, Kandiah P, Klopman
MA, Ribner BS, Tridandapani S, 2015. Performance of bed-
side diagnostic ultrasound in an Ebola isolation unit: the
Emory University Hospital experience. Am J Roentgenol 204:
1157–1159.
94. Mekky MA, Tolba M, Abdel-Malek MO, Abbas WA, Zidan M,
2015. Human fascioliasis: a re-emerging disease in upper
Egypt. Am J Trop Med Hyg 93: 76–79.
95. Teichmann D, Grobusch MP, Gobels K, Muller HP, Koehler W,
Suttorp N, 2000. Acute fascioliasis with multiple liver
abscesses. Scand J Infect Dis 32: 558–560.
96. Shim SS, Kim Y, Lee JK, Lee JH, Song DE, 2012. Pleuro-
pulmonary and abdominal paragonimiasis: CT and ultrasound
findings. Br J Radiol 85: 403–410.
97. Jeon HK, Lee D, Park H, Min DY, Rim HJ, Zhang H, Yang Y,
Li X, Eom KS, 2012. Human infections with liver and minute
intestinal flukes in Guangxi, China: analysis by DNA sequenc-
ing, ultrasonography, and immunoaffinity chromatography.
Korean J Parasitol 50: 391–394.
98. Mand S, Marfo-Debrekyei Y, Debrah A, Buettner M, Batsa L,
Pfarr K, Adjei O, Hoerauf A, 2005. Frequent detection of
worm movements in onchocercal nodules by ultrasonography.
Filaria J 4: 1.
99. Darge K, Troeger J, Engelke C, Leichsenring M, Nelle M,
Awadzi K, Buettner DW, 1994. Evaluation of ultrasonography
for the detection of drug-induced changes in onchocercal nod-
ules. Am J Trop Med Hyg 51: 800–808.
100. Poltera AA, Reyna O, Zea-Flores G, Beltranena F, Nowell de
Arevalo A, Zak F, 1991. Use of an ophthalmologic ultra-
soundscanner in human onchocercal skin nodules for non-
invasive sequential assessment during a macrofilaricidal trial
with amocarzine in Guatemala. The first experiences. Trop
Med Parasitol 42: 303–307.
101. Mazur-Melewska K, Jonczyk K, Modlinska-Cwalinska A,
Figlerowicz M, Sluzewski W, 2014. Visceral larva migrans syn-
drome: analysis of serum cytokine levels in children with
hepatic lesions confirmed in radiological findings. Parasite
Immunol 36: 668–673.
102. Brennan RC, Wilson MW, Kaste S, Helton KJ, McCarville MB,
2012. US and MRI of pediatric ocular masses with histopatho-
logical correlation. Pediatr Radiol 42: 738–749.
103. Umetsu S, Sogo T, Iwasawa K, Kondo T, Tsunoda T, Oikawa-
Kawamoto M, Komatsu H, Inui A, Fujisawa T, 2012. Intesti-
nal ascariasis at pediatric emergency room in a developed
country. World J Gastroenterol 20: 14058–14062.
104. Majid Z, Masood I, Pirzada MT, 2015. Ascaris lumbricoides
and its invasion of the accessory cystic duct: an unusual pre-
sentation. Trop Doct 45: 129–131.
105. Wu S, 2009. Sonographic findings of Ascaris lumbricoides in the
gastrointestinal and biliary tracts. Ultrasound Q 25: 207–209.
106. Pereira Junior Cde B, Markman Filho B, 2014. Clinical
and echocardiographic predictors of mortality in chagasic
cardiomyopathy—systematic review. Arq Bras Cardiol 102:
602–610.
107. Quintanilla-Cedillo MR, Leon-Urena H, Contreras-Ruiz J,
Arenas R, 2005. The value of Doppler ultrasound in diagnosis
in 25 cases of furunculoid myiasis. Int J Dermatol 44: 34–37.
108. Zha Y, Zhou M, Hari A, Jacobsen B, Mitragotri N, Rivas B,
Ventura OG, Boughton J, Fox JC, 2015. Ultrasound diagnosis
of malaria: examination of the spleen, liver, and optic nerve
sheath diameter. World J Emerg Med 6: 10–15.
109. Henriquez-Camacho C, Garcia-Casasola G, Guillen-Astete C,
Losa J, 2015. Ultrasound for the diagnosis of infectious dis-
eases: approach to the patient at point of care and at second-
ary level. J Infect 71: 1–8.
110. Polat Ekinci A, Karabacak E, Tekin L, Ozarmagan G, Ozcakar
L, 2015. Ultrasound imaging for the follow-up of patients with
leprosy: a pictorial essay. Br J Dermatol 172: 265–267.
111. Frade MA, Nogueira-Barbosa MH, Lugao HB, Furini RB,
Marques Junior W, Foss NT, 2013. New sonographic measures
of peripheral nerves: a tool for the diagnosis of peripheral
nerve involvement in leprosy. Mem Inst Oswaldo Cruz 108:
pii: S0074-02762013000300257.
20 BÉLARD AND OTHERS
112. Mirabel M, Bacquelin R, Tafflet M, Robillard C, Huon B,
Corsenac P, de Fremicourt I, Narayanan K, Meunier JM, Noel
B, Hagege AA, Rouchon B, Jouven X, Marijon E, 2015.
Screening for rheumatic heart disease: evaluation of a focused
cardiac ultrasound approach. Circulation 8: pii: e002324.
113. Heuvelings CC, Belard S, Janssen S, Wallrauch C, Grobusch
MP, Brunetti E, Giordani MT, Heller T, 2015. Chest ultraso-
nography in patients with HIV: a case series and review of the
literature. Infection doi:10.1007/s15010-015-0780-z.
114. Nabeta HW, Bahr NC, Rhein J, Fossland N, Kiragga AN, Meya
DB, Dunlop SJ, Boulware DR, 2014. Accuracy of noninvasive
intraocular pressure or optic nerve sheath diameter measure-
ments for predicting elevated intracranial pressure in crypto-
coccal meningitis. Open Forum Infect Dis 1: ofu093.
115. WHO, 1998. Training in diagnostic ultrasound: essentials, prin-
ciples and standards. Report of a WHO Study Group. World
Health Organ Tech Rep Ser 875: i–46, back cover.
116. Torres-Macho J, Anton-Santos JM, Garcia-Gutierrez I, de
Castro-Garcia M, Gamez-Diez S, de la Torre PG, Latorre-
Barcenilla G, Majo-Carbajo Y, Reparaz-Gonzalez JC, de
Casasola GG, 2012. Initial accuracy of bedside ultrasound
performed by emergency physicians for multiple indications
after a short training period. Am J Emerg Med 30: 1943–1949.
117. Short Course on Ultrasound in Infectious Diseases and Tropical
Medicine. Available at: www.tropicalultrasound.org. Accessed
May 17, 2015.
118. Clinical Ultrasound in Tropical Infectious Diseases. Available at:
http://www.tropicalultrasound.org/docs/Lima_Ultrasound_2015_
Registration.pdf. Accessed May 17, 2015.
119. New Course: Introduction to Ultrasound in Low Resource Set-
tings. Available at: http://www.lstmliverpool.ac.uk/about-lstm/
news-and-media/latest-news/2013/jan-june/new-course-cl03/.
Accessed May 15, 2015.
120. Adler D, Mgalula K, Price D, Taylor O, 2008. Introduction of a
portable ultrasound unit into the health services of the Lugufu
refugee camp, Kigoma District, Tanzania. Int J Emerg Med 1:
261–266.
121. Beira in Mozambique. Emergency Care Teaching Visit November
2012. Available at: http://www.emergencyultrasound.org.uk/20
.html. Accessed May 2, 2015.
122. 2012. FASH Ultrasound Course, 24 May, Krole Bu Teaching
Hospital, Accra, Ghana. Available at: http://www.tropical
ultrasound.org/FASH/FASH_report.pdf.
123. Jang TB, Ruggeri W, Dyne P, Kaji AH, 2010. Learning curve
of emergency physicians using emergency bedside sonography
for symptomatic first-trimester pregnancy. J Ultrasound Med
29: 1423–1428.
124. Jang TB, Casey RJ, Dyne P, Kaji A, 2010. The learning curve
of resident physicians using emergency ultrasonography for
obstructive uropathy. Acad Emerg Med 17: 1024–1027.
125. Tolsgaard MG, Todsen T, Sorensen JL, Ringsted C, Lorentzen
T, Ottesen B, Tabor A, 2013. International multispecialty con-
sensus on how to evaluate ultrasound competence: a Delphi
consensus survey. PLoS One 8: e57687.
126. WHO, 2011. WHO Manual of Diagnostic Ultrasound. Available
at: http://whqlibdoc.who.int/publications/2011/9789241547451_eng
.pdf. Accessed May 15, 2015.
127. Heller T, 2013. Focus Assessment with Sonography for HIV/TB:
A Practical Manual. Available at: http://www.talcuk.org/books/
focused-assessment-with-sonography-for-hivtb.htm. Accessed
May 15, 2015.
128. Partners in Health, 2011. Manual of Ultrasound for Resource-
Limited Settings. Available at: http://www.pih.org/library/manual-
of-ultrasound-for-resource-limited-settings. Accessed May 15,
2015.
129. American College of Emergency Physicians, 2008. Emer-
gency Ultrasound Guidelines. Available at: http://www.acep
.org/workarea/DownloadAsset.aspx?id=32878. Accessed May
15, 2015.
130. International Federation for Emergency Medicine, 2014. Point-
of-Care Ultrasound Curriculum Guidelines. Available at: http://
www.ifem.cc/site/DefaultSite/filesystem/documents/Policies%20
and%20Guidelines/IFEM%20Point-of-Care%20Ultrasound%20
Curriculum%20Guidelines%202014.pdf. Accessed May 15, 2015.
21POINT-OF-CARE ULTRASOUND IN TROPICAL MEDICINE
